|4May 11, 3:01 PM ET

HYPERION THERAPEUTICS INC 4

4 · HYPERION THERAPEUTICS INC · Filed May 11, 2015

Insider Transaction Report

Form 4
Period: 2015-05-07
Transactions
  • Disposition from Tender

    Common Stock

    2015-05-07$46.00/sh2,384,221$109,674,1660 total(indirect: See Note 2)
  • Disposition from Tender

    Common Stock

    2015-05-07$46.00/sh68$3,1280 total(indirect: See Note 4)
  • Disposition from Tender

    Common Stock

    2015-05-07$46.00/sh222$10,2120 total(indirect: See Note 3)
Footnotes (4)
  • [F1]Shares were tendered pursuant to the offer from Horizon Pharma plc to acquire shares of the Issuer.
  • [F2]The Reporting Person is a manager of NEA 12 GP, LLC, ("NEA 12 GP") which is the sole general partner of NEA Partners 12, Limited Partnership ("NEA Partners 12"). NEA Partners 12 is the sole general partner of New Enterprise Associates 12, Limited Partnership ("NEA 12"), the direct beneficial owner of the Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the Shares held by NEA 12 in which the Reporting Person has no pecuniary interest.
  • [F3]The Reporting Person is a member of PJ Barris, LLC, which is the direct beneficial owner of the Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the Shares held by PJ Barris, LLC in which the Reporting Person has no pecuniary interest.
  • [F4]The Reporting Person is the investment advisor of PDB LLC, which is the direct beneficial owner of the Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the Shares held by PDB LLC in which the Reporting Person has no pecuniary interest.

Documents

1 file
  • 4
    rrd424865.xmlPrimary